Kenneth Hoberman - 16 Jun 2023 Form 4 Insider Report for Nuvectis Pharma, Inc. (NVCT)

Role
Director
Signature
/s/ Kenneth Hoberman
Issuer symbol
NVCT
Transactions as of
16 Jun 2023
Transactions value $
$0
Form type
4
Filing time
20 Jun 2023, 08:15:07 UTC
Previous filing
22 Jul 2022
Next filing
29 Sep 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NVCT Common Stock Award $0 +18K +32.64% $0.00 73.1K 16 Jun 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The 18,000 shares of restricted Common Stock will vest in equal annual installments over three years beginning on the first anniversary of the grant date subject to Mr. Hoberman's continued service on the board on such dates.